Hiroyasu Muramatsu

Class B1 GPCR activation by an intracellular agonist

Kazuhiro Kobayashi, Kouki Kawakami, Tsukasa Kusakizako et al. · Nature · 2023 · 56 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Novel myostatin-specific antibody enhances muscle strength in muscle disease models

Hiroyasu Muramatsu, Taichi Kuramochi, Hitoshi Katada et al. · Scientific Reports · 2021 · 54 citations · Full text

Life Sciences, Immunology, Physiology +13

An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying

Kenichi Ozaki, Mitsu Onoma, Hiroyasu Muramatsu et al. · European Journal of Pharmacology · 2009 · 33 citations

Medicine, Pharmacology, Veterinary Physiology +15

Oral administration of MA-2029, a novel selective and competitive motilin receptor antagonist, inhibits motilin-induced intestinal contractions and visceral pain in rabbits

Hirokazu Sudo, Shoshin Yoshida, Kenichi Ozaki et al. · European Journal of Pharmacology · 2007 · 25 citations

Medicine, Pharmacology, Clinical Pharmacology +11

Smoking cessation increases levels of osteocalcin and uncarboxylated osteocalcin in human sera

Yasuhiro Kiyota, Hiroyasu Muramatsu, Yuiko Sato et al. · Scientific Reports · 2020 · 24 citations · Full text

Public Health, Endocrinology, Bone Metabolism +7